Public Profile

Germed Farmacêutica Ltda.

Germed Farmacêutica Ltda., commonly referred to as Germed Pharma, is a prominent player in the pharmaceutical industry, headquartered in Brazil. Established in 1991, the company has made significant strides in the development and production of high-quality generic medications, catering to both domestic and international markets. With a strong operational presence across various regions in Brazil, Germed Pharma focuses on therapeutic areas such as oncology, cardiology, and infectious diseases. The company is renowned for its commitment to innovation and quality, offering a diverse portfolio of products that meet stringent regulatory standards. Germed's dedication to research and development has positioned it as a leader in the generic pharmaceuticals sector, achieving notable milestones in expanding access to essential medications. Through its unwavering focus on excellence, Germed Farmacêutica Ltda. continues to enhance healthcare outcomes for patients worldwide.

DitchCarbon Score

DitchCarbon Score

How does Germed Farmacêutica Ltda.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Germed Farmacêutica Ltda.'s score of is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Germed Farmacêutica Ltda.'s reported carbon emissions

Germed Farmacêutica Ltda., headquartered in Brazil, currently does not have available data on its carbon emissions, as no specific emissions figures have been reported. Consequently, there are no documented reduction targets or climate commitments outlined by the company. In the absence of concrete emissions data, it is essential to note that many pharmaceutical companies are increasingly focusing on sustainability and reducing their carbon footprints in line with global climate initiatives. Germed's commitment to addressing climate change remains unclear, but the industry context suggests a growing emphasis on environmental responsibility.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Germed Farmacêutica Ltda.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Germed Farmacêutica Ltda. is in BR, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Germed Farmacêutica Ltda. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Aventis Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Glaxosmithkline

GB
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Genentech USA, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers